Literature DB >> 6603405

Urinary excretion of human epidermal growth factor (hEGF) in patients with malignant tumors.

M Uchihashi, Y Hirata, H Nakajima, T Fujita, S Matsukura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603405     DOI: 10.1055/s-2007-1018690

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  7 in total

Review 1.  Angiogenic factors as tumor markers.

Authors:  M Nguyen
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

2.  The level of urinary epidermal growth factor is not influenced by the extent of psoriatic lesions.

Authors:  S Kondo; N Sato; K Aso
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Chromosomal locations of the human and mouse genes for precursors of epidermal growth factor and the beta subunit of nerve growth factor.

Authors:  B U Zabel; R L Eddy; P A Lalley; J Scott; G I Bell; T B Shows
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  Immunoreactive low-molecular-weight epidermal growth factor in urine of patients with renal cell carcinoma.

Authors:  P le Coutre; S Bock; G Jakse; P E Petrides
Journal:  Urol Res       Date:  1992

5.  Epidermal and transforming growth factor alpha in patients with breast tumours.

Authors:  H Gregory; C E Thomas; I R Willshire; J A Young; H Anderson; A Baildam; A Howell
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

6.  Urinary epidermal growth factor (hEGF) levels in patients with carcinomas of the breast, colon and rectum.

Authors:  J W Sweetenham; D E Davies; S Warnes; P Alexander
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

7.  Urinary epidermal growth factor concentrations in various human malignancies.

Authors:  A L Mattila; I Saario; L Viinikka; O Ylikorkala; J Perheentupa
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.